CD44v6 was markedly upregulated in gastric cancer tissues, correlating with a worse prognosis and enhancing CSC traits by increasing the expression of key markers such as CD44, CD133, and EpCAM, as well as key transcription factors like Oct-4 and Nanog. This evidence concerns the gene EPCAM and gastric cancer.